Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by tickle1ston Mar 09, 2015 5:10pm

103 Views

Post# 23503795

RE:RE:RE:RE:RE:Sirona Pumping and Dumping

Ahhh Bigboots 13... are you saying he is calling you, Diamondslister and myself Rabble....and not the pigs unloading all those shares into the market that we've been seeing.

Like, who has access to millions and millions of shares to keep dumping? I think Stockeranus is wrong to call us rabble...very wrong.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features